ORBIMED ADVISORS LLC Q3 2021 Filing
Filed November 15, 2021
Portfolio Value
$9.1B
Holdings
170
Report Date
Q3 2021
Filing Type
13F-HR
All Holdings (170 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | EVHEVOLENT HEALTH INC | 595,000 | $18.4B | 202.71% | Call |
| 102 | —SYNLOGIC INC | 6,029,995 | $18.4B | 202.11% | |
| 103 | NXTCNEXTCURE INC | 2,711,013 | $18.3B | 200.81% | |
| 104 | 290ACHINOOK THERAPEUTICS INC | 1,420,637 | $18.1B | 199.21% | |
| 105 | —IMARA INC | 4,386,568 | $17.9B | 196.68% | |
| 106 | HUMAHUMACYTE INC | 1,500,000 | $17.4B | 191.39% | |
| 107 | NRIXNURIX THERAPEUTICS INC | 578,583 | $17.3B | 190.50% | |
| 108 | —FLEXION THERAPEUTICS INC | 2,769,383 | $16.9B | 185.65% | |
| 109 | RXSTRXSIGHT INC | 1,250,000 | $15.8B | 174.06% | |
| 110 | LUNGPULMONX CORP | 435,000 | $15.7B | 172.00% | |
| 111 | BLUBELLUS HEALTH INC NEW | 2,454,800 | $15.0B | 164.41% | |
| 112 | MISTMILESTONE PHARMACEUTICALS IN | 2,583,821 | $14.8B | 162.14% | |
| 113 | GLTOUSDGALECTO INC | 4,090,937 | $14.7B | 161.40% | |
| 114 | —DICE THERAPEUTICS INC | 440,000 | $14.4B | 158.36% | |
| 115 | —GRAYBUG VISION INC | 4,163,347 | $13.8B | 151.90% | |
| 116 | —MAGENTA THERAPEUTICS INC | 1,892,953 | $13.8B | 151.45% | |
| 117 | CVRXCVRX INC | 799,861 | $13.2B | 145.40% | |
| 118 | VORVOR BIOPHARMA INC | 833,333 | $13.1B | 143.60% | |
| 119 | 698ACHILLES THERAPEUTICS PLC | 1,584,845 | $12.3B | 135.68% | |
| 120 | AMGNAMGEN INC | 57,100 | $12.1B | 133.44% | |
| 121 | ACRSACLARIS THERAPEUTICS INC | 651,783 | $11.7B | 128.93% | |
| 122 | AVTEAEROVATE THERAPEUTICS INC | 535,714 | $11.2B | 123.51% | |
| 123 | GYRECATALYST BIOSCIENCES INC | 2,711,600 | $11.1B | 122.48% | |
| 124 | —9 METERS BIOPHARMA INC | 8,565,974 | $11.1B | 122.38% | |
| 125 | ALXOALX ONCOLOGY HLDGS INC | 150,000 | $11.1B | 121.76% | |
| 126 | KZRKEZAR LIFE SCIENCES INC | 1,263,400 | $10.9B | 119.96% | Call |
| 127 | IPSCCENTURY THERAPEUTICS INC | 407,047 | $10.2B | 112.55% | |
| 128 | WHWKAADI BIOSCIENCES INC | 346,262 | $10.2B | 111.77% | |
| 129 | —ONCOCYTE CORP | 2,856,000 | $10.2B | 111.73% | |
| 130 | MAPSWM TECHNOLOGY INC | 700,400 | $10.2B | 111.61% | |
| 131 | NVV1NOVAVAX INC | 45,580 | $9.4B | 103.84% | |
| 132 | CTMXCYTOMX THERAPEUTICS INC | 1,821,868 | $9.3B | 101.91% | |
| 133 | KALAKALA PHARMACEUTICALS INC | 3,438,998 | $9.0B | 99.02% | |
| 134 | NAUTNAUTILUS BIOTECHNOLOGY INC | 1,452,774 | $8.9B | 98.03% | |
| 135 | PHGEBIOMX INC | 2,813,489 | $8.6B | 94.61% | |
| 136 | BMRNBIOMARIN PHARMACEUTICAL INC | 110,900 | $8.6B | 94.19% | |
| 137 | —CONVEY HLDG PARENT INC | 1,000,000 | $8.4B | 92.31% | |
| 138 | —SYROS PHARMACEUTICALS INC | 1,837,500 | $8.2B | 90.27% | |
| 139 | REGNREGENERON PHARMACEUTICALS | 13,560 | $8.2B | 90.18% | |
| 140 | NBPI MAB | 111,120 | $8.1B | 88.52% | |
| 141 | NSTG 2.625 03/01/25NANOSTRING TECHNOLOGIES INC | 6,000,000 | $7.9B | 86.33% | |
| 142 | XENEXENON PHARMACEUTICALS INC | 477,000 | $7.3B | 80.10% | |
| 143 | ASNSUSDX4 PHARMACEUTICALS INC | 1,373,849 | $7.3B | 79.87% | |
| 144 | NTLAINTELLIA THERAPEUTICS INC | 53,200 | $7.1B | 78.43% | |
| 145 | —FIELD TRIP HEALTH LTD | 1,538,470 | $7.0B | 76.88% | |
| 146 | SURFUSDSURFACE ONCOLOGY INC | 909,666 | $6.9B | 75.68% | |
| 147 | OWLTOWLET INC | 1,200,000 | $6.7B | 73.72% | |
| 148 | SRPTSAREPTA THERAPEUTICS INC | 64,700 | $6.0B | 65.75% | |
| 149 | —PROMETHEUS BIOSCIENCES INC | 250,000 | $5.9B | 65.15% | |
| 150 | NBTXNANOBIOTIX SA | 500,000 | $5.7B | 62.42% | |
| 151 | —APTOSE BIOSCIENCES INC | 2,594,348 | $5.7B | 62.16% | |
| 152 | PRCTPROCEPT BIOROBOTICS CORP | 135,000 | $5.2B | 56.60% | |
| 153 | —HEALTH SCIENCES ACQ CORP 2 | 500,000 | $4.9B | 54.34% | |
| 154 | SGHTSIGHT SCIENCES INC | 200,000 | $4.5B | 49.89% | |
| 155 | RGENREPLIGEN CORP | 14,724 | $4.3B | 46.76% | |
| 156 | —LANDOS BIOPHARMA INC | 283,217 | $4.1B | 45.44% | |
| 157 | ADAGADAGENE INC | 275,000 | $4.0B | 43.41% | |
| 158 | CABACABALETTA BIO INC | 302,509 | $3.7B | 40.43% | |
| 159 | SNDXSYNDAX PHARMACEUTICALS INC | 190,600 | $3.6B | 40.02% | |
| 160 | —ASLAN PHARMACEUTICALS LTD | 1,970,000 | $3.5B | 38.54% | |
| 161 | INZYINOZYME PHARMA INC | 294,000 | $3.4B | 37.44% | |
| 162 | —TALARIS THERAPEUTICS INC | 247,240 | $3.4B | 36.85% | |
| 163 | TARAPROTARA THERAPEUTICS INC | 450,000 | $3.1B | 34.22% | |
| 164 | IFRXINFLARX NV | 1,064,118 | $2.8B | 30.29% | |
| 165 | —STRONGBRIDGE BIOPHARMA PLC | 794,675 | $1.6B | 17.81% | |
| 166 | —LONGBOARD PHARMACEUTICALS IN | 113,500 | $1.0B | 11.03% | |
| 167 | MAPSWWM TECHNOLOGY INC | 150,200 | $649.0M | 7.13% | Call |
| 168 | —PHASEBIO PHARMACEUTICALS INC | 177,113 | $551.0M | 6.06% | |
| 169 | —APTINYX INC | 153,285 | $359.0M | 3.95% | |
| 170 | AZNASTRAZENECA PLC | 5,200 | $312.0M | 3.43% | Call |
| 171 | —OWLET INC | 220,704 | $207.0M | 2.27% | Call |
PreviousPage 2 of 2